CLINICAL_TRIALS
trial_result
· 2024-10-30
Clinical Trial Update: Fecal Microbiota Transplant (FMT) in Melanoma Patients [Phase 2]
Summary
A Phase 2 trial evaluating fecal microbiota transplant in melanoma has completed, with results posted on 2024-10-30.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Zarour, Hassane, MD | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-30